期刊文献+

泌尿生殖道支原体感染及药敏结果分析 被引量:3

Analysis of mycoplasma detection and its susceptibility to antibiotics of urogenital tract infection
在线阅读 下载PDF
导出
摘要 目的了解解脲支原体(UU)和人型支原体(MH)在泌尿生殖道系统感染中的致病作用及对抗生素的敏感情况。方法对554例泌尿系感染患者进行支原体培养,并对阳性标本进行10 种抗生素药敏试验。采用支原体培养、鉴定、药敏一体化试剂盒进行检测。结果 554例患者中支原体阳性347例。感染率为62.6%,UU、MH以及UU+MH混合感染的阳性率分别为51.3%、1.1%和10.3%,女性感染率明显高于男性(P<0.01),支原体对10种抗生素敏感性最高的是强力霉素 (DOX)(92.6%),其次为克拉霉素(CLA)(87%)、美满霉素(MIN)(83.5%)和阿奇霉素(AZI) (82.8%)。结论泌尿生殖系统感染患者支原体感染率为62.6%,主要由UU引起,占81.8%(284/ 347),应首选DOX治疗。 Objective To explore the pathogeniosis of ureaplasma urealyticum(UU)and myco plasraa hominis(MH) in urogenital tract infection and their susceptibility to antibiotics. Methods My coplasma culture was carried out with the samples of 554 cases and then the susceptibility to 10 kinds of antibibtics was detected on positive samples. The culture, identification and the drug susceptibility were carried out with one complex mycoplasma kit. Results 347 of 554 cases were infected with myco plasma,the total positive rate was 62. 6% ;the positive rates of UU,MH and mixed with infection were 51. 3%,1.1% and 10. 3 %, respectively. The positive rate of female was higer than that of male(P< 0.01). The most sensitive antibiotics was DOX(92. 6%), CLA (87%), MIN (83. 5%) and AZI (82. 8%). Conclusion Mycoplasma infection rate is 62. 6% in urogenital tract infection. The major mycoplasma is UU 81. 8%(284/347). DOX may be selected as the first drug to treat mycoplasma infection.
作者 赵辉 朱树民
出处 《检验医学与临床》 CAS 2005年第1期10-11,14,共3页 Laboratory Medicine and Clinic
关键词 泌尿生殖道 支原体感染 药敏试验 人型支原体 解脲支原体 抗生素 Ureaplasma urealyticum Urogenital diseases Mycoplasma infections Mi-crobial sensitivity test
  • 相关文献

参考文献11

二级参考文献42

  • 1叶元康 王慕娣.新支原体成品培养基的研究[J].中华流行病学杂志,1998,19(3):222-222.
  • 2蒋冬香.解脲支原体对6种抗生素的敏感性[J].上海医学检验杂志,2000,15(2):92-92.
  • 3[1]Gilbert GL.Treatment of chlamydial and mycoplasmal genital infections[J].Med J Aust,1987,146:205-208.
  • 4[2]Polisseni F,Bambirra EA,Camargos AF.Detection of chronic endometritis by diagnostic hysteroscopy in asymptomatic infertile patients[J].Gynecol Obstet Ivest,2003,55(4):205-210.
  • 5[3]Asche V,King H,Kovacs GT,et al.Chlamydia trachomatis infection in 1300 fertile and inferile women in Melboume.Proceeding s of the 12th World Congress of Fertility and Sterility[P].Singapore,1986,223.
  • 6[4]Simms I,Eastick K,Mallinson H,et al.Associations between mycoplasma genitalium,chlamydia trachomatis and pelvic inflammatory disease[J].Clin Pathol,2003,56(8):616-618.
  • 7[5]Kovacs GT,Wectcott M,Rusden J,et al.The prevalence of Chlamydia trachomatis in a young,sexually-activ population[J].Med J Aust,1987,147:550-552.
  • 8[6]Toomey KE.Rafferty,Stamm WE.Unrecognized high prevalence of Chlamydia trachomatis cervical infaction in an isolated Alaskan Eskimo population[J].JAMA,1987,257:53-56.
  • 9[7]Bowie WR.Willetts V.Suboptimal efficacy of erythromycin and tetracycline against vaginal Ureaplasma urealyticum[J].Sex Transm Dis,1987,14:88-91.
  • 10叶于运.性传播疾病(第1版)[M].南京:江苏科技出版社,1998.132.

共引文献377

同被引文献12

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部